Gurgaon, India
Tata 1mg is India’s leading consumer health platform, with a mission to make healthcare accessible, understandable, and affordable for a billion Indians. Founded in 2015, the platform enables consumers to learn more about their medicines, find cost-effective substitutes, and access a doctor platform to revolutionize how healthcare professionals are found. In addition, its diagnostics service brings transparency and cost-effectiveness to lab tests.
With a focus on public service, Tata 1mg aims to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price. The application is available as a web portal– www.1mg.com and as a mobile app across Android/iOS. The company recently secured a $40.00M Venture Round investment on 06 September 2022, with participation from HBM Healthcare Investments, MPOF Mauritius, Rubal Jain, MAF Mauritius, Tata Digital, KWE Beteiligungen, and Vardaan Sharma.
Tata 1mg operates within the industries of E-Commerce, Health Care, and Pharmaceutical, positioning itself as a key player in the Indian healthcare market. With its innovative approach and strong investor support, Tata 1mg is well-positioned for further growth and impact in the country's healthcare sector.
